other past behaviors demonstrating inappropriateness for acting as capital market business personnel.  Investors are strongly advised to always verify transaction confirmation documents to make sure

breaches of securities law, he can always submit such supportive information or evidence to the SEC for further investigation; otherwise, the SEC will again exercise it statutory power for evidence

transactions. 2Total of each segment may not always tally with consolidated financials due to holding segment. 3 3Core EBITDA is Reported EBITDA less Inventory gains/(losses). 4Core Net Profit is Reported Net

financials are based upon elimination of intra-company or intra-business segment) transactions. 2Total of each segment may not always tally with consolidated financials due to holding segment. 3Core EBITDA is

Chemicals and Packaging. ***2Q19 Core Financials exclude IRSL 1Consolidated financials are based upon elimination of intra-company or intra-business segment transactions. 2Total of each segment may not always

may not always tally with consolidated financials due to holding segment. 3Core EBITDA is Reported EBITDA less Inventory gains/(losses). 4Core Net Profit is Reported Net Profit less Inventory gains

16% 0.87 0.71 0.75 16% 1Consolidated financials are based upon elimination of intra-company (or intra-business segment) transactions 2Total of each segment may not always tally with consolidated

not always tally with consolidated financials due to holding segment 3Excludes price adjustment for captive sales on freight saving. This does not have any impact on regional or consolidated EBITDA

to thank all stakeholders, including shareholders, suppliers, customers and other related parties, who have always trusted and supported the Company. We also thank all the dedicated and hardworking

investment advice and disseminating analysis reports and information of listed firms to investors. Hence, the ASCO and securities company members always place high importance on corporate governance and